Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines

Kohichi Yamazaki, Hiroshi Isobe, Tarou Hanada, Tomoko Betsuyaku, Atsushi Hasegawa, Nobuyuki Hizawa, Shigeaki Ogura, Yoshikazu Kawakami

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds